| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Relay Therapeutics, Inc.'s insiders have reduced their positions by a net 6,210,786 shares worth roughly $120.4M. In the past 30 days, 0 insiders bought and 2 sold.
All 2 insiders who sold still hold shares after their sales. RLAY sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 21.90M | $424.96M | - | |
| CEO | 471.3K | $8.53M | -48,199 | |
| Pres | 399.1K | $7.57M | - | |
| Other | 223.7K | $4.48M | - | |
| CFO | 105.1K | $1.95M | -17,717 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 1,459 | $18.61 | $27,151.99 | -0.9% | -0.6% | - | |
| Jul 28, 2026 | Bergstrom Donald A74 | President, R&D | Sell | 2,237 | $18.61 | $41,630.57 | -0.5% | -0.6% | - | |
| Jul 7, 2026 | Patel Sanjiv73 | President and CEO | Sell10b5-1 | 48,199 | $19.58 | $943,736.42 | -7.3% | -1.8% | - | |
| Jul 6, 2026 | Bergstrom Donald A74 | President, R&D | Sell10b5-1 | 8,660 | $18.71 | $162,028.60 | -2.1% | +2.6% | - | |
| Jul 6, 2026 | Catinazzo Thomas69 | Chief Financial Officer | Sell10b5-1 | 17,717 | $18.69 | $331,130.73 | -10.0% | +2.6% | - | |
| Jun 30, 2026 | Rahmer Peter61 | See Remarks | Sell10b5-1 | 50,000 | $19.09 | $954,500.00 | -18.1% | -5.5% | - | |
| Jun 22, 2026 | Catinazzo Thomas69 | Chief Financial Officer | Sale+OE10b5-1 | 187,163 | $16.97 | $3,176,864.79 | -51.3% | +5.3% | - | |
| Jun 22, 2026 | Bergstrom Donald A74 | President, R&D | Sale+OE10b5-1 | 93,456 | $16.94 | $1,583,144.64 | -18.3% | +5.3% | - | |
| May 14, 2026 | Catinazzo Thomas69 | Chief Financial Officer | Sell10b5-1 | 17,717 | $12.86 | $227,840.62 | -8.3% | +57.0% | - | |
| Apr 28, 2026 | Bergstrom Donald A74 | President, R&D | Sell | 1,490 | $14.79 | $22,037.10 | -0.4% | +43.1% | - |